| Advances in GPCR Modeling evaluated by the GPCR Dock 2013 I Kufareva, V Katritch, P Biggin, M Kim, K Park, SW Jung, AE Cho, ... Structure 22, 1120-1139, 2014 | 192 | 2014 |
| Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: Novel sulfamoylcarbamates and sulfamides derived from acetophenones A Akıncıoğlu, H Akıncıoğlu, İ Gülçin, S Durdagi, CT Supuran, S Göksu Bioorganic & medicinal chemistry 23 (13), 3592-3602, 2015 | 155 | 2015 |
| Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds B Özgeriş, S Göksu, LP Köse, I Gülçin, RE Salmas, S Durdagi, F Tümer, ... Bioorganic & medicinal chemistry 24 (10), 2318-2329, 2016 | 154 | 2016 |
| Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies S Göksu, A Naderi, Y Akbaba, P Kalın, A Akıncıoğlu, I Gülçin, S Durdagi, ... Bioorganic chemistry 56, 75-82, 2014 | 139 | 2014 |
| Strategies in the rational drug design T Mavromoustakos, S Durdagi, C Koukoulitsa, M Simcic, ... Current medicinal chemistry 18 (17), 2517-2530, 2011 | 134 | 2011 |
| Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site S Durdagi, M Şentürk, D Ekinci, HT Balaydın, S Göksu, Öİ Küfrevioğlu, ... Bioorganic & medicinal chemistry 19 (4), 1381-1389, 2011 | 128 | 2011 |
| Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues … S Durdagi, T Mavromoustakos, N Chronakis, MG Papadopoulos Bioorganic & medicinal chemistry 16 (23), 9957-9974, 2008 | 126 | 2008 |
| Identification of novel cholesterol-binding regions in Kir2 channels A Rosenhouse-Dantsker, S Noskov, S Durdagi, DE Logothetis, I Levitan Journal of Biological Chemistry 288 (43), 31154-31164, 2013 | 114 | 2013 |
| Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies H Cavdar, M Senturk, M Guney, S Durdagi, G Kayik, CT Supuran, D Ekinci Journal of enzyme inhibition and medicinal chemistry 34 (1), 429-437, 2019 | 105 | 2019 |
| Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain S Durdagi, HJ Duff, SY Noskov Journal of chemical information and modeling 51 (2), 463-474, 2011 | 98 | 2011 |
| Nanoscale enzyme inhibitors: Fullerenes inhibit carbonic anhydrase by occluding the active site entrance A Innocenti, S Durdagi, N Doostdar, TA Strom, AR Barron, CT Supuran Bioorganic & medicinal chemistry 18 (8), 2822-2828, 2010 | 96 | 2010 |
| Combinatorial peptide library screening for discovery of diverse α-glucosidase inhibitors using molecular dynamics simulations and binary QSAR models A Mollica, G Zengin, S Durdagi, R Ekhteiari Salmas, G Macedonio, ... Journal of Biomolecular Structure and Dynamics 37 (3), 726-740, 2019 | 93 | 2019 |
| Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug binding S Durdagi, S Deshpande, HJ Duff, SY Noskov Journal of chemical information and modeling 52 (10), 2760-2774, 2012 | 85 | 2012 |
| The synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors A Akıncıoğlu, E Kocaman, H Akıncıoğlu, RE Salmas, S Durdagi, İ Gülçin, ... Bioorganic Chemistry 74, 238-250, 2017 | 80 | 2017 |
| In Silico Drug Screening Approach for the Design of Magic Bullets: A Successful Example with Anti-HIV Fullerene Derivatized Amino Acids S Durdagi, CT Supuran, TA Strom, N Doostdar, MK Kumar, AR Barron, ... Journal of chemical information and modeling 49 (5), 1139-1143, 2009 | 79 | 2009 |
| 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors S Durdagi, T Mavromoustakos, MG Papadopoulos Bioorganic & medicinal chemistry letters 18 (23), 6283-6289, 2008 | 73 | 2008 |
| Synthesis, anticholinesterase activity and molecular modeling study of novel carbamate-substituted thymol/carvacrol derivatives BZ Kurt, I Gazioglu, A Dag, RE Salmas, G Kayık, S Durdagi, F Sonmez Bioorganic & medicinal chemistry 25 (4), 1352-1363, 2017 | 68 | 2017 |
| Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study SB Mirza, RE Salmas, MQ Fatmi, S Durdagi Journal of Molecular Graphics and Modelling 66, 99-107, 2016 | 67 | 2016 |
| Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors R Çakmak, S Durdagi, D Ekinci, M Şentürk, G Topal Bioorganic & medicinal chemistry letters 21 (18), 5398-5402, 2011 | 65 | 2011 |
| Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies A Politi, S Durdagi, P Moutevelis-Minakakis, G Kokotos, ... Journal of Molecular Graphics and Modelling 29 (3), 425-435, 2010 | 64 | 2010 |
Ramin Ekhteiari SalmasLondon, United Kingdom, King's College LondonE-mail megerősítve itt: kcl.ac.uk